logo
AAT Bioquest

iFluor® IRDye 800RS Maleimide

Product key features

  • Near-Infrared Fluorescence – Exhibits optimal excitation/emission in the NIR spectrum, reducing background autofluorescence for high-sensitivity detection.
  • Reactive Maleimide Functionalization – reacts selectively with thiol groups, ensuring stable covalent attachment to thiol-modified DNA and RNA.
  • Balanced Solubility – Enhanced hydrophobicity improves performance in organic solvents while maintaining aqueous compatibility.
  • High-Purity Conjugates – Labeled nucleic acids can be efficiently isolated via reverse-phase chromatography, minimizing unreacted dye contamination.
  • Versatile Applications – Suitable for fluorescence-based hybridization assays, molecular imaging, and nucleic acid-based diagnostics.
  • Chemical Stability – Maintains structural integrity under standard labeling and purification conditions, ensuring reproducible performance.

Product description

iFluor® IRDye 800RS is a near-infrared fluorescent dye engineered for nucleic acid labeling applications. It exhibits high water solubility but reduced salt tolerance compared to iFluor® IRDye 800 CW. The increased hydrophobicity of iFluor® IRDye 800RS enhances its performance in organic solvent-based reactions while maintaining sufficient aqueous solubility, making it particularly suitable for conjugation to thiol-modified oligonucleotides and nucleic acids.

The maleimide-functionalized derivative of iFluor® IRDye 800RS undergoes rapid and selective Michael addition with thiol groups under physiological conditions, enabling stable covalent attachment to thiol-modified DNA and RNA. This conjugation strategy is widely utilized in fluorescence-based hybridization assays, molecular imaging, and diagnostic applications. Following conjugation, labeled nucleic acids can be purified via reverse-phase chromatography, yielding high-purity conjugates with minimal residual unreacted dye.

The physicochemical properties of iFluor® IRDye 800RS provide a controlled balance between aqueous and organic solubility, optimizing its utility in diverse labeling strategies requiring near-infrared fluorescence. iFluor® IRDye 800RS, manufactured by AAT Bioquest, is structurally identical to IRDye 800RS (IRDye® is the trademark of LI-COR).

Example protocol

PREPARATION OF STOCK SOLUTIONS

Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles

Prepare iFluor® IRDye 800RS Maleimide stock solution
  1. Allow the vial of iFluor Dye maleimide to warm up to room temperature.
  2. Add anhydrous DMSO to the vial to prepare a 10 mM dye stock solution.
  3. Vortex the vial briefly to fully dissolve the dye, and then centrifuge to collect the dye at the bottom of the vial.
  4. Protect all stock solutions from light as much as possible by wrapping containers in aluminum foil.
Prepare antibody or protein solution for labeling
  1. If your protein already contains a thiol group, prepare the protein at 50-100 uM (for example: 5mg/ml BSA is ~75uM) in 50~100 mM MES buffer or buffers of your choice with pH 6.5~7.0.
  2. If labeling with an intact antibody, reduction of disulfide bonds need to be carried out before maleimide reaction. Prepare antibody in 2-10 mg/ml in a suitable buffer with pH 7.0–7.5. A 10-fold molar excess of a reducing agent such as DTT or TCEP is added to the antibody. If DTT is used, it must be removed by dialysis or desalting to a suitable buffer with pH 6.5~7.0 prior to conjugation. If TCEP is used, it is not necessary to remove excess TCEP during conjugation with maleimides, however, removal of TCEP by dialysis or desalting prior to conjugation gives the better labeling efficiency.

    Below is a sample protocol for generating free thiol groups on antibody:
    1. Prepare 2-10mg/ml IgG solution in PBS.
    2. Prepare a fresh solution of 1 M DTT (15.4 mg/100 µL) in distilled water. 
    3. Add 1- 20 µL of DTT stock per ml of IgG solution while mixing. 
    4. Let the solution stand at room temperature for 30 minutes without additional mixing (to minimize the re-oxidation of cysteines to cystines). 
    5. Pass the reduced IgG over a filtration column pre-equilibrated with 50 mM MES buffer (pH=6.5) to remove excess DTT.
    6. Determine the antibody concentrations. This can be done either spectrophotometrically or colorimetrically.
    7. Carry out the conjugation as soon as possible after this step.

    Note: For the best results, IgG solutions should be > 2 mg/mL.

    Note: The reduction can be carried out in almost any buffer from pH 7 to 7.5, e.g., MES, phosphate, or TRIS buffers.

    Note: Steps 5 can be replaced by dialysis.

     
  3. If your protein doesn’t have a free thiol group or disulfide bond to reduce, a thiolation modification need to be carried out before maleimide conjugation (for example:  using 2-Iminothiolane or 2-IT) to introduce sulfhydryl (-SH) groups to the original amino groups on protein.

SAMPLE EXPERIMENTAL PROTOCOL

This labeling protocol was developed for the labeling IgG with iFluor® Dye maleimide. Further optimization may be required for your specific proteins.

Note: Each protein requires a distinct dye/protein ratio, which also depends on the properties of dyes. Over-labeling of a protein could detrimentally affect its binding affinity while the protein conjugates of low dye/protein ratio give reduced sensitivity.

Run Conjugation Reaction
  1. Use a 10~20:1 molar ratio of iFluor Dye Maleimide : IgG as the starting point. While stirring or vortexing the protein solution, add a volume of dye stock solution to result in a dye: protein molar ratio of 10-20. For example, for 5mg/ml IgG (~33 uM), you would add dye to a final concentration of 0.33-0.66 mM.

    Note: We recommend using a 10:1 molar ratio of dye to protein.  If the ratio is too low or too high, determine the optimal dye/protein ratio at 5:1, 15:1, and 20:1, respectively.
  2. Continue to rotate or shake the reaction mixture at room temperature for 30-60 minutes.
Purify the Conjugation
The following protocol is an example of dye-protein conjugate purification by using a Sephadex G-25 column.
  1. Purify the conjugate on a gel filtration column, such as a Sephadex G-25 column or equivalent matrix, or by extensive dialysis at 4°C in an appropriate buffer.

Recommended AAT Desalting Columns:

Volume of Reaction Catalog#
0.6-1.0mL

Cat#60504: PD-10 Column

https://www.aatbio.com/products/readiuse-disposable-pd-10-desalting-column?unit=60504
~0.1mL

Cat#60500: Spin Column

https://www.aatbio.com/products/readiuse-bio-gel-p-6-spin-column?unit=60500 

Optional: Characterize the Desired Dye-Protein Conjugate

Determining the Degree of Substitution (DOS) is crucial in characterizing dye-labeled proteins. Lower DOS proteins tend to have weaker fluorescence, but higher DOS proteins may also have reduced fluorescence. For most antibodies, the optimal DOS is between 2 and 10, depending on the dye and protein properties. For effective labeling, the degree of substitution should be controlled to have 5-8 moles of iFluor® IRDye 800RS Maleimide to one mole of antibody. The following steps are used to determine the DOS of iFluor® IRDye 800RS Maleimide-labeled proteins:

  1. Measure absorption— To measure the absorption spectrum of a dye-protein conjugate, the sample concentration should be kept between 1 and 10 µM (For example: IgG conjugate: 10uM is ~1.5mg/ml), depending on the dye's extinction coefficient. 
  2. Read OD (absorbance) at 280 nm and dye maximum absorption (ƛ max = 767 nm for iFluor® IRDye 800RS Maleimide). For most spectrophotometers, the sample (from the column fractions) must be diluted with de-ionized water so that the OD values range from 0.1 to 0.9. The O.D. (absorbance) at 280 nm is the maximum absorption of protein, while 767 nm is the maximum absorption of iFluor® IRDye 800RS Maleimide. To obtain accurate DOS, ensure the conjugate is free of the non-conjugated dye.
  3. Calculate DOS using our DOS calculator: https://www.aatbio.com/tools/degree-of-labeling-calculator

Spectrum

References

View all 50 references: Citation Explorer
Detection properties of indium-111 and IRDye800CW for intraoperative molecular imaging use across tissue phantom models.
Authors: Sever, ReidAnn E and Rosenblum, Lauren T and Stanley, Kayla C and Cortez, Angel G and Menendez, Dominic M and Chagantipati, Bhuvitha and Nedrow, Jessie R and Edwards, W Barry and Malek, Marcus M and Kohanbash, Gary
Journal: Journal of biomedical optics (2025): S13705
Bright and Specific Targeting of Metastatic Lymph Nodes in Orthotopic Mouse Models of Gastric Cancer with a Fluorescent Anti-CEA Antibody.
Authors: Cox, Kristin E and Amirfakhri, Siamak and Lwin, Thinzar M and Hosseini, Mojgan and Ghosh, Pradipta and Obonyo, Marygorret and Hoffman, Robert M and Yazaki, Paul J and Bouvet, Michael
Journal: Annals of surgical oncology (2025)
Systematic comparison of fluorescence imaging in the near-infrared and shortwave-infrared spectral range using clinical tumor samples containing cetuximab-IRDye800CW.
Authors: Keizers, Bas and Nijboer, Thomas S and van der Fels, Christa A M and van den Heuvel, Marius C and van Dam, Gooitzen M and Kruijff, Schelto and Jan de Jong, Igle and Witjes, Max J H and Voskuil, Floris J and Gorpas, Dimitris and Browne, Wesley R and van der Zaag, Pieter J
Journal: Journal of biomedical optics (2025): S13708
The Use of Fluorescent Markers to Detect and Delineate Head and Neck Cancer: A Scoping Review.
Authors: Srinivasan, Akash and Kaminskaite, Viktorija and Winter, Stuart C
Journal: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervi (2025): 220-240
Preclinical evaluation of zirconium-89 labeled anti-Trop2 antibody-drug conjugate (Trodelvy) for imaging in gastric cancer and triple-negative breast cancer.
Authors: Huang, Wenpeng and Li, Liming and Zhou, Yuhan and Yang, Qi and Mixdorf, Jason C and Barnhart, Todd E and Hsu, Jessica C and Saladin, Rachel J and Liu, Chihao and Rosenkrans, Zachary T and Engle, Jonathan W and Gao, Jianbo and Kang, Lei and Cai, Weibo
Journal: European journal of nuclear medicine and molecular imaging (2025)
Page updated on June 29, 2025

Ordering information

Price
Unit size
1 mg
5 mg
Catalog Number
7161671617
Quantity
Add to cart

Additional ordering information

Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Request quotation

Physical properties

Molecular weight

1079.21

Solvent

DMSO

Spectral properties

Excitation (nm)

767

Emission (nm)

785

Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22

Storage

Freeze (< -15 °C); Minimize light exposure
UNSPSC12171501
Product Image
Product Image
Gallery Image 1
Fluorescent dye maleimides are the most popular tool for conjugating dyes to a peptide, protein, antibody, thiol-modified oligonucleotide, or nucleic acid through their SH group. Maleimides react readily with the thiol group of proteins, thiol-modified oligonucleotides, and other thiol-containing molecules under neutral conditions. The resulting dye conjugates are quite stable.